The US medical and healthcare market is the single biggest market in the world representing 47.5 % of all global healthcare expenditures. The market is growing at almost a 10% rate and the share of imported products and technologies is 32% and rising. Healthcare reform (ObamaCare), a growing elderly population with an associated disease burden, changing regulatory guidelines, new drug launches, and a growing mobile and wellness sector are drivers.
9630942363 Genuine Call Girls In Ahmedabad Gujarat Call Girls Service
Finpro market opportunity healthcare usa
1. OBAMACARE - A NEW OPPORTUNITY IN US HEALTHCARE
The US medical and healthcare market is the single
biggest market in the world representing 47.5 %
of all global healthcare expenditures. The market
is growing at almost a 10% rate and the share of
imported products and technologies is 32% and
rising.
Healthcare reform (ObamaCare), a growing elderly
population with an associated disease burden,
Breakdown of the healthcare expenditures in the US by
category, 2011
changing regulatory guidelines, new drug launches,
and a growing mobile and wellness sector are
Other Items
21 % Hospital care
31 %
drivers. Research, structures
and equipment
investments
6%
Prescription drugs
10 %
Physician and clinical
Nursing home and services
home health 20 %
8% Dental care
4%
Source: US Gov.
2. PHARMACEUTICALS, MEDICAL DEVICES AND BIOTECHNOLOGY
OPERATING ROOM EQUIPMENT The US biotechnology revenues formed ca. 70% of global public
The US pharmaceutical market is a several hundred billion dollar biotech companies’ revenues in 2011. The decline in revenues of
industry. Generic pharmaceuticals, a $53 billion dollar industry, is US biotech companies in 2011 was driven by three large
expected to be one of the fastest-growing acquisitions by non-biotech acquirers – after normalizing for
sectors in the country with average expected growth of 6.3% until these acquisitions, the revenues increased by 12%. In 2011 the
2017. Medical devices and hospital and operating room solutions US FDA approved more new drugs than at any time since 2004.
and equipment are also lucrative and growing market segments. Around 70% of the approvals were approved in US before they
Additional emerging field is the electronic medical data and received approval anywhere else in the world. As in prior years,
electronic records market, wellness/preventative medicine and cancer continues to dominate the US clinical pipeline. Neurology
mobile health will become increasingly important in the years ahead as aging
populations increase the number of neurodegenerative diseases.
Eero Toivainen Kimmo Aura Finpro Address
Senior Consultant Regional Sales Manager, Americas Helsinki Porkkalankatu 1
eero.toivainen(a)finpro.fi kimmo.aura(a)finpro.fi PL 358 00180 Helsinki
Tel +358 40 343 3379 Tel +358 40 504 8317 00181 Helsini Tel: +358 (0) 204 6951
Fax: +358 (0) 204 695 200 www.finpro.fi
www.finpro.fi/web/english-pages/opportunities-worldwide Email: info@finpro.fi
3. HOSPITAL EQUIPMENT AND MEDICAL DEVICES HEALTHCARE INFORMATICS AND MOBILE HEALTH
The US medical device market constitutes 47% of global The global mHealth market is expected grow at a CAGR of 41.5%
markets and is estimated to top $200 billion in 2020. The biggest and to reach $10.2 billion by 2018. The US is the largest market
segments are the orthopedic devices, in Vitro Diagnostics (IVD), for mHealth solutions with a size of $660 million or ca. 50% of
cardiovascular devices, and ophthalmic devices. During 2010-2020 the global market. The monitoring services are the largest and
the fastest growing segments are expected to be the orthopedic fastest growing mHealth segment constituting 60% of the total
devices, IVD, and hospital supplies. Especially the patient market followed by diagnostic services and healthcare systems.
monitoring device market is expected to grow rapidly in the Cardiac rhythm management, sleep therapy and ambulatory ECG
coming years. Major drivers are aging population, high healthcare are the main monitoring device segments – sleep therapy, blood
spending, early diagnosis of diseases, high prevalence of chronic pressure monitoring, glucose monitoring and medication
diseases, sedentary lifestyle of US population, and health tourism. adherence are predicted gain more momentum. Strong growth
forecasted for mHealth applications while an additional emerging
field is the electronic records market. Cloud computing, spread
of smartphones, ease of use functionalities, rising health-care
spending, and demand for independent aging solutions and
post-acute care service are driving the growth of mHealth.
Eero Toivainen Kimmo Aura Finpro Address
Senior Consultant Regional Sales Manager, Americas Helsinki Porkkalankatu 1
eero.toivainen(a)finpro.fi kimmo.aura(a)finpro.fi PL 358 00180 Helsinki
Tel +358 40 343 3379 Tel +358 40 504 8317 00181 Helsini Tel: +358 (0) 204 6951
Fax: +358 (0) 204 695 200 www.finpro.fi
www.finpro.fi/web/english-pages/opportunities-worldwide Email: info@finpro.fi